Dashboard
Manage Tickers

ETTX Entasis Therapeutics Holdin...

Nasdaq www.entasistx.com


$ -0.01 (-0.45 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 623.48 $ 0.00 (0 %)
DIA $ 470.64 $ 0.00 (0 %)
SPY $ 676.34 $ 0.00 (0 %)
TLT $ 89.77 $ 0.00 (0 %)
GLD $ 367.00 $ 0.00 (0 %)
$ 2.19
-- x --
-- x --
-- - --
$ 1.40 - $ 3.88
68,834
na
104.8M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-27-2022 03-31-2022 10-Q
2 03-03-2022 12-31-2021 10-K
3 11-04-2021 09-30-2021 10-Q
4 08-12-2021 06-30-2021 10-Q
5 05-05-2021 03-31-2021 10-Q
6 03-23-2021 12-31-2020 10-K
7 11-05-2020 09-30-2020 10-Q
8 08-06-2020 06-30-2020 10-Q
9 05-07-2020 03-31-2020 10-Q
10 03-11-2020 12-31-2019 10-K
11 11-14-2019 09-30-2019 10-Q
12 08-12-2019 06-30-2019 10-Q
13 05-14-2019 03-31-2019 10-Q
14 03-29-2019 12-31-2018 10-K
15 11-14-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

over-42-million-bet-on-this-biotechnology-stock-4-penny-stocks-insiders-are-buying
Over $42 Million Bet On This Biotechnology...
07/14/2022 12:15:56

US producer prices are likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, foc...

entasis-therapeutics-highlights-presentation-of-data-on-sulbactam-durlobactam-and-etx0462-at-2022-asm-microbe-annual-conference
Entasis Therapeutics Highlights Presentati...
06/09/2022 12:10:32

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and ...

58-biggest-movers-from-yesterday
58 Biggest Movers From Yesterday
05/24/2022 09:29:12

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its co...

innoviva-acquires-astrazeneca-spin-off-at-220share
Innoviva Acquires AstraZeneca-Spin Off At ...
05/23/2022 14:04:44

entasis-therapeutics-shares-resume-trade
Entasis Therapeutics Shares Resume Trade
05/23/2022 13:01:09

entasis-therapeutics-shares-to-resume-trade-at-900-am
Entasis Therapeutics Shares To Resume Trad...
05/23/2022 12:56:51

Core News & Articles
Innoviva To Acquire Entasis Therapeutics F...
05/23/2022 12:38:47

benzingas-top-ratings-upgrades-downgrades-for-may-6-2022
Benzinga's Top Ratings Upgrades, Downgrade...
05/06/2022 14:02:00

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-...

10-biggest-price-target-changes-for-friday
10 Biggest Price Target Changes For Friday
05/06/2022 12:51:45

Keybanc cut HubSpot, Inc. (NYSE: HUBS) price target from $535 to $461. HubSpot shares fell 0.4% to $340.00 in pre-market tr...

cantor-fitzgerald-downgrades-entasis-therapeutics-hldg-to-neutral-lowers-price-target-to-2
Cantor Fitzgerald Downgrades Entasis Thera...
05/06/2022 08:54:31

Cantor Fitzgerald analyst Louise Chen downgrades Entasis Therapeutics Hldg (NASDAQ:ETTX) from Overweight to Neutral and lowe...

entasis-therapeutics-hldg-q1-earnings-insights
Entasis Therapeutics Hldg: Q1 Earnings Ins...
04/27/2022 13:02:13

  Entasis Therapeutics Hldg (NASDAQ:ETTX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here'...

entasis-therapeutics-hldg-q1-eps-032-down-from-029-yoy
Entasis Therapeutics Hldg Q1 EPS $(0.32) D...
04/27/2022 11:39:36

Entasis Therapeutics Hldg (NASDAQ:ETTX) reported quarterly losses of $(0.32) per share. This is a 10.34 percent decrease over l...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/26/2022 12:31:36

 

entasis-therapeutics-highlights-presentation-of-efficacy-safety-data-from-its-phase-3-attack-trial-at-european-congress-of-clinical-microbiology-and-infectious-diseases-conference
Entasis Therapeutics Highlights Presentati...
04/26/2022 12:03:43

Presentations Highlight Topline Results, Sub-Analysis for sulbactam-durlobactam (SUL-DUR) WALTHAM, Mass., April 26, 2022 (GLOB...

benzingas-top-ratings-upgrades-downgrades-for-march-16-2022
Benzinga's Top Ratings Upgrades, Downgrade...
03/16/2022 15:07:49

Upgrades

alliance-global-partners-downgrades-entasis-therapeutics-hldg-to-neutral
Alliance Global Partners Downgrades Entasi...
03/16/2022 12:32:54

Alliance Global Partners analyst James Molloy downgrades Entasis Therapeutics Hldg (NASDAQ:ETTX) from Buy to Neutral.

Core News & Articles
Innoviva Says On March 15 Revised Its Non-...
03/15/2022 13:14:31

-SEC Filing

benzingas-top-ratings-upgrades-downgrades-for-march-8-2022
Benzinga's Top Ratings Upgrades, Downgrade...
03/08/2022 15:04:25

Upgrades

wedbush-downgrades-entasis-therapeutics-hldg-to-neutral-lowers-price-target-to-18
Wedbush Downgrades Entasis Therapeutics Hl...
03/08/2022 12:05:40

Wedbush analyst Robert Driscoll downgrades Entasis Therapeutics Hldg (NASDAQ:ETTX) from Outperform to Neutral and lowers the...

benzingas-top-ratings-upgrades-downgrades-for-march-4-2022
Benzinga's Top Ratings Upgrades, Downgrade...
03/04/2022 15:04:14

Upgrades

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION